Week of February 21, 2023 |
|
Oh Well
I really thought the Eagles were going to win the Super Bowl. It would have been so nice. But sports, like life, can be both thrilling and disappointing. One never knows what next year might bring, but Philly should be competitive next year as well. We shall see. On to baseball …
|
|
Celebrating BellRinger 2022’s Success
|
|
Use Pivot to Find Funding Opportunities
Pivot is a database primarily of funding opportunities that is available to members of Georgetown University. First-time users will need to create an account first with their Georgetown email. With your account, you can save searches and receive email alerts with new opportunities.
|
|
Application Period Closes This Friday: Diversity in Cancer Research Summer 2023 Undergraduate Internship Program
Program details:
- Ten-week full-time program available beginning June 5 ($5,000 stipend).
- In-person/virtual workshops, seminars, scientific meetings, mentoring and career development activities during the 2023-2024 academic year.
- Carefully matched mentors and peer mentors for each intern.
- Georgetown campus housing now offered for in-person interns
|
|
Center for Healthy Aging Symposium Abstracts Due February 28
Abstracts are being accepted for the Second Annual Georgetown Center for Healthy Aging Symposium, “Advancing Knowledge About Aging to Improve Health and Health Care,” which takes place July 12. The symposium, held in-person and online, will include posters, oral presentations and panel discussions on special topics such as new research collaborations, career development, community outreach and grant proposal development. Upload abstracts via this Google Form. Contact Bill Rebeck, PhD, or Pamela Saunders, PhD, with questions.
|
|
Shared Resources Spotlight |
|
This weekly series showcases Georgetown University’s Shared Resources, which provide Georgetown Lombardi researchers with access to state-of-the-art equipment and technical expertise to support their work. |
|
Survey, Recruitment & Biospecimen Collection Shared Resource
The Survey, Recruitment & Biospecimen Collection Shared Resource (SRBSR) provides Georgetown Lombardi investigators with access to an integrated suite of comprehensive services for planning and implementing research projects. SRBSR services include consultation prior to study initiation, survey design and administration, screening for eligibility, subject recruitment, database programming to facilitate participant tracking, biospecimen acquisition, and preparing and managing final datasets. The SRBSR maintains and continuously updates a centralized, unified and efficient patient registry (Georgetown MedStar Research Registry [GMR2]) and the Familial Cancer Registry (FCR) to facilitate subject recruitment and biospecimen acquisition. The majority (97%) of subjects currently enrolled in this patient registry have consented to have their samples retained for future studies and to be contacted about future studies for which they may be eligible. The SRBSR serves the needs of investigators from various disciplines, including behavioral scientists, clinical and translational researchers, epidemiologists and basic scientists.
|
|
Thursday, February 23
12:00 - 1:00 p.m.
Chris Jennings, founder and president of Jennings Policy Strategies Inc., presents this special Department of Medicine Grand Rounds focused on the politics of health care reform. Join this talk in Goldberg Auditorium, MedStar Georgetown University Hospital and via Zoom.
|
|
“African Americans in Healthcare: Privacy, Consent and Trust”
Thursday, February 23
4:00 - 5:30 p.m.
This presentation features Kim P. Gunter, vice president and chief compliance and privacy officer at Drexel University, as part of a monthly development series focused on issues related to diversity, equity, inclusion, belonging and anti-racism. Sponsored by Georgetown University School of Nursing. Register for this presentation, held in the New Research Building Auditorium and via Zoom.
|
|
Friday, February 24
12:00 - 1:00 p.m.
Presented by Charles Craik, PhD, professor of pharmaceutical chemistry, UCSF, associate director for translational laboratory research and co-leader, Molecular Oncology Program, Helen Diller Family Comprehensive Cancer Center. Join this lecture via Zoom.
|
|
Friday, February 24
2:00 - 3:00 p.m.
|
|
Friday, February 24
3:00 - 4:00 p.m.
Presented by Gregory Gallanis, MD-PhD candidate in Tumor Biology. Mentor: Ann Riegel, PhD. Join this presentation in the Warwick Evans Room, Building D, and via Zoom.
|
|
Funding and Award Opportunities |
|
NEW Damon Runyon Fellowship Award
The Damon Runyon Fellowship Award supports the training of the brightest postdoctoral scientists as they embark upon their research careers. This funding enables them to be mentored by established investigators in leading research laboratories across the country. Applicants must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. Candidates must apply for the fellowship under the guidance of a Sponsor — a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. View additional eligibility criteria. This four-year award provides $60,000, $62,000, $64,000, and $66,000 in stipend support for years one, two, three, and four, respectively. In addition, an annual $2,000 expense allowance is awarded to the laboratory in which the Fellow is working and can be used by the Fellow for their educational and scientific expenses. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year. View application guidelines. Application deadline: 4:00 p.m. ET, March 15, submitted through ProposalCentral.
|
|
Cancer Screening Research Network Funding Opportunities
The National Cancer Institute Division of Cancer Prevention has released three funding opportunity announcements for applications to create the Cancer Screening Research Network (CSRN). The CSRN will conduct rigorous, multi-center cancer screening trials and studies to evaluate emerging technologies and strategies for the purpose of cancer screening. The CSRN will have three different components for an integrated network.
View the following links for more information about each funding opportunity:
-
RFA-CA-23-020: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
-
RFA-CA-23-021: Statistics and Data Management Center (UG1 Clinical Trial Required)
-
RFA-CA-23-022: Coordinating and Communication Center (UG1 Clinical Trial Required)
Application deadline: 5:00 p.m. ET, February 28
|
|
Request for Applications: Aging & Cancer Research with The Israel Cancer Research Fund
The Samuel Waxman Cancer Research Foundation and The Israel Cancer Research Fund are accepting applications for collaborative proposals to focus on aging and cancer. Projects must involve collaboration between two research groups — one in the U.S. and one in Israel — with different, but complementary expertise. Proposals must justify the partnership through synergistic scientific aims. Two collaborative projects will be funded. Each of these projects will be awarded $200,000 per year for two years, or a total of $400,000, with each research group receiving $100,000 per year ($200,000 total). Successful projects may be eligible for a third year of funding at the level of $100,000 ($50,000 per research group). View full RFA guidelines. Submit letters of intent via email by 5:00 p.m. ET, March 1 to Wylie Tene at wtene@waxmancancer.org.
|
|
BRCA Research and Education (CureBRCA) Grants
BRCA Research & Cure Alliance (CureBRCA) is now accepting funding applications for BRCA-related initiatives that involve prevention, detection, screening, and/or treatment for men at risk for BRCA-related cancers. All grant applications must address one of the following: identification of at-risk carriers, cancer prevention, early detection and screening for cancer, or novel treatment approaches pertaining to BRCA-related cancers. BRCA research, educational initiatives, or outreach efforts that cater to men who are at risk for BRCA mutations are desired. Applications that include collaboration, either across institutions, or within a single institution will be prioritized. Applications submitted from junior faculty or from underrepresented groups are encouraged. Applicants can request up to $500,000. View RFA for more information about eligibility, funding, evaluation, key dates, and application portal. Application deadline: March 1.
|
|
AAI Careers in Immunology Fellowship Program
The AAI Careers in Immunology Fellowship Program supports the career development of young scientists by providing eligible PIs with one year of salary support for a trainee in their labs. The fellowship does not pay fringe benefits or other indirect costs to the institution. PIs must be independent research scientists who are AAI regular members in good standing. At the time of application, the PI should have no more than $350,000 U.S. dollars in total annual direct costs (excluding PI salary) from all funding sources, including start-up funds. Trainees must be AAI members in good standing at the time of application and have a current Trainee Certification Form on record with AAI. AAI encourages applications from and for women and underrepresented minority scientists. Award consideration is based on the merit of the PI’s proposed project, potential of the trainee, the quality of the training environment, and financial need. View application instructions. Deadline: 11:59 p.m. ET, March 15.
|
|
Children’s Cancer Foundation 2023 Call for Proposals
The Children's Cancer Foundation, Inc. (CCF) invites individuals from Maryland, D.C. and Northern Virginia conducting research and/or programs relevant to pediatric cancer to submit proposals for grant award consideration. CCF will be awarding multiple one-year grants for research; one one-year grant for research by a young investigator (Giant Food NextGen Award); and several one-year grants for support of an existing or new program that serves the pediatric cancer community. Applications must be submitted via email or file transfer service to Rose Ann Verrilli: rverrilli@childrenscancerfoundation.org no later than May 7 at 11:59 p.m. ET. Review and download application materials and guidelines.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Onc Board Review | Podium A / Zoom
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 81202; phone: 202-796-7323)
12:15 PM | No Conference | Podium A / Zoom
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom (dial 646-558-8656; Meeting ID: 941 1630 5835)
12:15 PM | Testicular/Germ Cell Tumors – Dr. Dawson | Podium A / Zoom
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Zoe Malchiodi | “Novel Natural Killer Cell Interactions in the Pancreatic Ductal Adenocarcinoma Tumor Microenvironment” | W302 New Research Building or Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Esophageal Cancer – Dr. Mukherji | Podium A / Zoom
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: “Targeting an Intracellular Oncoprotein in MHC 1 for Immunotherapy” | Charles Craik, PhD | Zoom
12:00 PM | No Lecture | Zoom
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
